Cargando…

Serum bilirubin concentration is modified by UGT1A1 Haplotypes and influences risk of Type-2 diabetes in the Norfolk Island genetic isolate

BACKGROUND: Located in the Pacific Ocean between Australia and New Zealand, the unique population isolate of Norfolk Island has been shown to exhibit increased prevalence of metabolic disorders (type-2 diabetes, cardiovascular disease) compared to mainland Australia. We investigated this well-establ...

Descripción completa

Detalles Bibliográficos
Autores principales: Benton, M. C., Lea, R. A., Macartney-Coxson, D., Bellis, C., Carless, M. A., Curran, J. E., Hanna, M., Eccles, D., Chambers, G. K., Blangero, J., Griffiths, L. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4667444/
https://www.ncbi.nlm.nih.gov/pubmed/26628212
http://dx.doi.org/10.1186/s12863-015-0291-z
_version_ 1782403829059289088
author Benton, M. C.
Lea, R. A.
Macartney-Coxson, D.
Bellis, C.
Carless, M. A.
Curran, J. E.
Hanna, M.
Eccles, D.
Chambers, G. K.
Blangero, J.
Griffiths, L. R.
author_facet Benton, M. C.
Lea, R. A.
Macartney-Coxson, D.
Bellis, C.
Carless, M. A.
Curran, J. E.
Hanna, M.
Eccles, D.
Chambers, G. K.
Blangero, J.
Griffiths, L. R.
author_sort Benton, M. C.
collection PubMed
description BACKGROUND: Located in the Pacific Ocean between Australia and New Zealand, the unique population isolate of Norfolk Island has been shown to exhibit increased prevalence of metabolic disorders (type-2 diabetes, cardiovascular disease) compared to mainland Australia. We investigated this well-established genetic isolate, utilising its unique genomic structure to increase the ability to detect related genetic markers. A pedigree-based genome-wide association study of 16 routinely collected blood-based clinical traits in 382 Norfolk Island individuals was performed. RESULTS: A striking association peak was located at chromosome 2q37.1 for both total bilirubin and direct bilirubin, with 29 SNPs reaching statistical significance (P < 1.84 × 10(−7)). Strong linkage disequilibrium was observed across a 200 kb region spanning the UDP-glucuronosyltransferase family, including UGT1A1, an enzyme known to metabolise bilirubin. Given the epidemiological literature suggesting negative association between CVD-risk and serum bilirubin we further explored potential associations using stepwise multivariate regression, revealing significant association between direct bilirubin concentration and type-2 diabetes risk. In the Norfolk Island cohort increased direct bilirubin was associated with a 28 % reduction in type-2 diabetes risk (OR: 0.72, 95 % CI: 0.57-0.91, P = 0.005). When adjusted for genotypic effects the overall model was validated, with the adjusted model predicting a 30 % reduction in type-2 diabetes risk with increasing direct bilirubin concentrations (OR: 0.70, 95 % CI: 0.53-0.89, P = 0.0001). CONCLUSIONS: In summary, a pedigree-based GWAS of blood-based clinical traits in the Norfolk Island population has identified variants within the UDPGT family directly associated with serum bilirubin levels, which is in turn implicated with reduced risk of developing type-2 diabetes within this population. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12863-015-0291-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4667444
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46674442015-12-03 Serum bilirubin concentration is modified by UGT1A1 Haplotypes and influences risk of Type-2 diabetes in the Norfolk Island genetic isolate Benton, M. C. Lea, R. A. Macartney-Coxson, D. Bellis, C. Carless, M. A. Curran, J. E. Hanna, M. Eccles, D. Chambers, G. K. Blangero, J. Griffiths, L. R. BMC Genet Research Article BACKGROUND: Located in the Pacific Ocean between Australia and New Zealand, the unique population isolate of Norfolk Island has been shown to exhibit increased prevalence of metabolic disorders (type-2 diabetes, cardiovascular disease) compared to mainland Australia. We investigated this well-established genetic isolate, utilising its unique genomic structure to increase the ability to detect related genetic markers. A pedigree-based genome-wide association study of 16 routinely collected blood-based clinical traits in 382 Norfolk Island individuals was performed. RESULTS: A striking association peak was located at chromosome 2q37.1 for both total bilirubin and direct bilirubin, with 29 SNPs reaching statistical significance (P < 1.84 × 10(−7)). Strong linkage disequilibrium was observed across a 200 kb region spanning the UDP-glucuronosyltransferase family, including UGT1A1, an enzyme known to metabolise bilirubin. Given the epidemiological literature suggesting negative association between CVD-risk and serum bilirubin we further explored potential associations using stepwise multivariate regression, revealing significant association between direct bilirubin concentration and type-2 diabetes risk. In the Norfolk Island cohort increased direct bilirubin was associated with a 28 % reduction in type-2 diabetes risk (OR: 0.72, 95 % CI: 0.57-0.91, P = 0.005). When adjusted for genotypic effects the overall model was validated, with the adjusted model predicting a 30 % reduction in type-2 diabetes risk with increasing direct bilirubin concentrations (OR: 0.70, 95 % CI: 0.53-0.89, P = 0.0001). CONCLUSIONS: In summary, a pedigree-based GWAS of blood-based clinical traits in the Norfolk Island population has identified variants within the UDPGT family directly associated with serum bilirubin levels, which is in turn implicated with reduced risk of developing type-2 diabetes within this population. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12863-015-0291-z) contains supplementary material, which is available to authorized users. BioMed Central 2015-12-02 /pmc/articles/PMC4667444/ /pubmed/26628212 http://dx.doi.org/10.1186/s12863-015-0291-z Text en © Benton et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Benton, M. C.
Lea, R. A.
Macartney-Coxson, D.
Bellis, C.
Carless, M. A.
Curran, J. E.
Hanna, M.
Eccles, D.
Chambers, G. K.
Blangero, J.
Griffiths, L. R.
Serum bilirubin concentration is modified by UGT1A1 Haplotypes and influences risk of Type-2 diabetes in the Norfolk Island genetic isolate
title Serum bilirubin concentration is modified by UGT1A1 Haplotypes and influences risk of Type-2 diabetes in the Norfolk Island genetic isolate
title_full Serum bilirubin concentration is modified by UGT1A1 Haplotypes and influences risk of Type-2 diabetes in the Norfolk Island genetic isolate
title_fullStr Serum bilirubin concentration is modified by UGT1A1 Haplotypes and influences risk of Type-2 diabetes in the Norfolk Island genetic isolate
title_full_unstemmed Serum bilirubin concentration is modified by UGT1A1 Haplotypes and influences risk of Type-2 diabetes in the Norfolk Island genetic isolate
title_short Serum bilirubin concentration is modified by UGT1A1 Haplotypes and influences risk of Type-2 diabetes in the Norfolk Island genetic isolate
title_sort serum bilirubin concentration is modified by ugt1a1 haplotypes and influences risk of type-2 diabetes in the norfolk island genetic isolate
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4667444/
https://www.ncbi.nlm.nih.gov/pubmed/26628212
http://dx.doi.org/10.1186/s12863-015-0291-z
work_keys_str_mv AT bentonmc serumbilirubinconcentrationismodifiedbyugt1a1haplotypesandinfluencesriskoftype2diabetesinthenorfolkislandgeneticisolate
AT leara serumbilirubinconcentrationismodifiedbyugt1a1haplotypesandinfluencesriskoftype2diabetesinthenorfolkislandgeneticisolate
AT macartneycoxsond serumbilirubinconcentrationismodifiedbyugt1a1haplotypesandinfluencesriskoftype2diabetesinthenorfolkislandgeneticisolate
AT bellisc serumbilirubinconcentrationismodifiedbyugt1a1haplotypesandinfluencesriskoftype2diabetesinthenorfolkislandgeneticisolate
AT carlessma serumbilirubinconcentrationismodifiedbyugt1a1haplotypesandinfluencesriskoftype2diabetesinthenorfolkislandgeneticisolate
AT curranje serumbilirubinconcentrationismodifiedbyugt1a1haplotypesandinfluencesriskoftype2diabetesinthenorfolkislandgeneticisolate
AT hannam serumbilirubinconcentrationismodifiedbyugt1a1haplotypesandinfluencesriskoftype2diabetesinthenorfolkislandgeneticisolate
AT ecclesd serumbilirubinconcentrationismodifiedbyugt1a1haplotypesandinfluencesriskoftype2diabetesinthenorfolkislandgeneticisolate
AT chambersgk serumbilirubinconcentrationismodifiedbyugt1a1haplotypesandinfluencesriskoftype2diabetesinthenorfolkislandgeneticisolate
AT blangeroj serumbilirubinconcentrationismodifiedbyugt1a1haplotypesandinfluencesriskoftype2diabetesinthenorfolkislandgeneticisolate
AT griffithslr serumbilirubinconcentrationismodifiedbyugt1a1haplotypesandinfluencesriskoftype2diabetesinthenorfolkislandgeneticisolate